LETTERS

TO THE

competency-based model to psychiatric education for medical students. Medical educators have applied many of the principles of competency-based instruction to various aspects of the medical school curriculum. Although more sophisticated methods of evaluation and instruction have been developed (1 , 2), most of this work has been carried out in

overdose patient in perspective. A systematic management of consecutive overdose cases the reader with a better idea of the frequency

the teaching

been

of medical

specialties

other

than

psychiatry

and

in the allied health professions. Some of this work has involved the teaching of psychological principles to nonpsychiatric health professionals (3, 4). More recently, there have been attempts to apply principles of instructional design (including the specification of performance objectives and objective evaluation measures) to psychiatric teaching. Examples of this include the teaching of interviewing techniques (5), psychopathology (6), and clinical clerkship experiences (7). Unfortunately, we know of no fully integrated four-year psychiatry curriculum in a medical school wherein formative and summative evaluation is carried out. We are presently involved in the development of a competencybased psychiatric clerkship at the University of California School of Medicine, with the goal of achieving such an integrated model.

We hope

that

as more

programs

attempt

to apply

the corn-

petency-based model to psychiatric education, more definitive work will be carried out in the critical areas of medical student education and teaching competency.

REFERENCES 1. Barrows H: Simulated Patients. Springfield, Ill, Charles C Thomas, 1972 2. Harless WG, Drennan CG, Marxer JJ, et al: Case: a computeraided simulation of the clinical encounter. J Med Educ 46:443448, 1971 3. Weinstein HM, Gould BG, Russell ML: Interviewing skills for respiratory therapists: a teaching module, 1976 (unpublished manuscript) 4. Bland C, Houge D, Filiatrault L, et al: Developing an objective based curriculum for family practice residency. J Family Practice (in press) 5. Endow Al, Adler LM, Wexler M: Programmed instruction in interviewing: an experiment in medical education. JAMA 212:1843-1846, 1970 6. Randels PM, Kilpatrick DG, McCurdy L, et al: Comparison of the psychiatry learning system and traditional teaching of psychiatry. J Med Educ 51:751-757, 1976 7. Meyerson A, Wachtel A: Utilization of a videotape based test to evaluate competence of psychiatric clerks and aspects of a teaching program. Paper presented at the Conference on Research in Medical Education, American Association of Medical Colleges, San Francisco, Nov 13-14, 1976

ic clinical agement.

findings and In addition,

overdose

with

of the

MICHAEL

Overdosing

the Tricyclic

Overdose

M.

WEINSTEIN,

L. RUSSELL, San Francisco,

tricyclic with

would

measurements adverse

provide

(which

effects,

evidence

manof the

have

contrary

to one

of a tricyclic

over-

regarding the treatment of tri(1). We have studied a group of 45 consecutively hospitalized patients with tricyclic antidepressant overdose, using serial plasma determinations and documentation of physical findings for up to 144 hours. In our experience, the prompt use of respiratory support, which avoids hypoxia that may prompt cardiac arrhythmias, has been adequate in most cases. Overzealous use of drugs in treating the overdose patient may create medical emergencies rather than solve them.

The following

conclusions overdoses

is a list of findings

from

our own

experience

and the literature that are contrary to points raised in the two papers referred to above. 1 . The use of ipecac rather than gastric lavage may stimulate seizures and result in the aspiration ofgastric contents. 2. Treatment of tricyclic overdose patients with adrenal corticosteroids is contraindicated, since these drugs have been reported to inhibit tricyclic metabolism in animals (2) and have inhibited tricyclic metabolism in 1 patient in our series who had a concurrent neurological illness. 3. Overhydration of the patient is to be avoided because

the

direct

pressants

myocardial makes

depressant

the

patient

ure (3). Antiarrhythmic

effect

prone

drugs

must

of tricyclic

to congestive

be used

with

antideheart

fail-

caution

be-

cause many of them are cardiac depressants. 4. The casual use of physostigmine to arouse a tricyclic overdose patient (even if the patient has not been further overdosed with hypnotics) is certainly not diagnostic of a tncyclic overdose and is seldom of any sustained clinical value in patients with severe tnicyclic overdoses that have been documented by plasma measurements. That the patient descnbed by Dns. Holinger and Klawans remained in the intensive care unit for 10 days prior to extubation indicated physostigmine did not produce an immediate recovery. The clinician must also be aware that physostigmine can be lethal

if the patient

has

a junctional

rhythmia. 5. Major tricyclic absence of emergency es in our series have

100 or more ingestion

We agree

M.D. PH.D.

plasma

and justify antidepressant

report of the would provide of such dramat-

the need for such drastic clinical documentation of the severity

to correlate

reports)

dose cyclic

drug HARVEY

found

EDITOR

or idioventricular

cardiac

drug ingestions can be diagnosed room tnicyclic plasma assays; had QRS durations on routine

milliseconds

within

the first

24 hours

ar-

in the all casECGs of

after

the

(4).

that the use of 74 mg of physostigmine

in one

patient in a 6-hour period and 193 mg in another who remained in coma for several days is worth reporting; however, we question whether either report will decrease medical complications after tricyclic antidepressant overdose.

Calif

Patient REFERENCES

SIR:

We

read

‘ ‘

Reversal

of Tricyclic-Overdosage-Induced

Central Anticholinergic Syndrome by Physostigmine’ by Paul C. Holinger, M.D., and Harold L. Klawans, M.D., and ‘

“Treatment

noz,

M.D.

of Tricyclic

(September

Intoxication”

1976 issue)

by

with

Rodrigo

initial

A.

interest

Mu-

and

subsequent dismay. The findings in the single case presented in each paper are so different from our own that we think they deserve comment in order to keep management of the

1. Petit JM, Spiker DO, Ruwitch JF, et al: Tricyclic antidepressant plasma levels and adverse effects in 40 overdose cases. Clin Pharmacol Ther (in press) 2. Von Bahr C, Sjoqvist F, Orrenius 5: The inhibitory effect of hydrocortisone and testosterone on plasma disappearance of nortriptyline in the dog and profused rat liver. Eur J Pharmacol 9:106-110, 1970 3. Laddu AR, Lomani P: Desipramine toxicity and its treatment.

Am J Psychiatry

134:4,

April

1977

461

LETTERS

TO THE

Toxicol

EDITOR

Appl Pharmacol

4. Spiker

DG,

Weiss

AN,

overdose:

clinical

col Ther

18:539-546,

15:287-294, Chang

1969

2. Kline

55, et al: Tricyclic

presentation

and plasma

antidepressant

levels.

Clin Pharma-

T. BIGG5,

JOHN

A.

M.D.

E.

VINCENT

4.

M.D.

RIESENBERG,

M.D.

ZIEGLER,

St.

Louis,

5.

Mo.

6.

Dr.

Munoz SIR:

Dr.

carefully its

and

Biggs

or they

content,

Holinger

Drs.

and

purpose,

and

proposals

cyclic

any that

outlined

by

of the



My paper

1 1 supportive

for emergency

and

treatment

antidepressants.

Dr.

Biggs

criticizing

short

it as

paragraph

and

associates

offers

three

criticisms

with do not

trioffer

they indicate has been useful

that merit

consideration.

First, without reference or clinical data, the authors reject the induction ofemesis with ipecac because they are worried about seizures and aspiration. They advocate exclusive use

of stomach lavage, tory complications state of knowledge reference

alert

which is also known to produce respiraand to trigger seizures (1). The present does not favor a dogmatic attitude (e.g.,

2). Induction

patient

of vomiting

who has just

patient who is becoming stomach lavage, which tubation.

Second, sostigmine,’

taken

which

to be ideal

an overdose,

for the

whereas

the

progressively obtunded may require is safer if preceded by tracheal in-

the letter complains ‘

seems

no one

about has



‘the casual

advocated.

use of phy-

As stated

in step

1 1 of my schedule, physostigmine is used for cardiovascular and central nervous system effects ofanticholinergic medication. Until Dr. Biggs and associates produce evidence to refute the findings of those who have advocated these selective ofphysostigmine (3-6), their position appears uncritical and prejudicial. If they are withholding this effective treatment for the specific manifestations outlined in my paper, they should clarify their medical, legal, and logical justifications. Third, the letter decries the use of physostigmine as a diagnostic tool, something I have not suggested. On the other hand, in order to prevent readers of their letter from thinking that the clinician should wait for blood level studies before treating the patient for tricyclic overdose, I should mention that the evidence on the value of blood levels in tricyclic intoxication, even that provided by the St. Louis group (7), is still equivocal; most hospitals do not have the technique available, and many patients have been successfully treated uses

on the basis of clinical observations. learned (at the same center where have their laboratory) that chances tory tion.

measurement

can

ever

replace

careful

clinical

RH:

ment,

7th ed. Los

Handbook

Altos,

Lange

Diagnosis

Medical

1971

462

Am J Psychiatry

134:4,

April

1977

and

Treat-

NJ.

A.

M.D.

MUNOZ,

Wis.

SIR: The purpose of our paper was to draw attention to the central anticholingeric syndrome caused by phenothiazines and antiparkinson medication in addition to tricyclic antidepressants, with a focus on two manifestations of the syndrome, coma and movement abnormalities (myoclonus and choreoathetosis), and their reversal by physostigmine. The clinical efficacy and theoretical implications of reversal of

the central been

well

anticholinergic

syndrome

documented

in the

by physostigmine

anesthesia

have

general medical literature as well as in psychiatric journals (1-6). This documentation has included several hundred patients in investigations ranging from controlled double-blind studies to reports

and

on consecutive cases. Dr. Biggs and associates’ letter is also directed Munoz’ article, which may confuse the issues. like

to distinguish

Munoz.

our

In particular,

purpose

and

findings

we reiterate

of diazepam, barbiturates, tion for seizure-like activity scribed as myoclonic jerks

toward Dr. We would

from

our caution

those

about

of Dr.

the use

or other anticonvulsive medicathat may be more accurately deand choreoathetosis.

REFERENCES 1. Greene LT: Physostigmine treatment ofanticholinergic drug depression in postoperative patients. Anesth Analg (Cleve) 50:222-226, 1971 2. Duvoisin RC, Katz R: Reversal of central anticholinergic syndrome in man by physostigmine. JAMA 206:1963-1965, 1968 3. El-Yousef M, Janowsky DS, Davis JM, et al: Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study. Am J Psychiatry 130:141-145, 1973 4. Burks JS, Walker JE, Rumack BH, et al: Tricyclic antidepressant poisoning: reversal of coma, choreoathetosis, and myoclonus by physostigmine. JAMA 230: 1405-1407, 1974 5. Bernards W: Case history number 74: reversal of phenothiazineinduced coma with physostigmine. Anesth Analg (Cleve) 52:938-941, 1973 6. Snyder BD: Physostigmine and anticholinergic poisoning.

JAMA

233:1165-1166,

1975 PAUL

C.

M.D.

HOLINGER,

L. KLAWANS,

HAROLD

observa-

Publications,

Drugs:

Oradell,

Sheboygan,

M.D. Ill.

Chicago, Criteria

of Poisoning:

Calif.

A:Psychotropic

of Overdose.

RODRIGO

I am glad to note that I Dr. Biggs and associates are slim that any labora-

REFERENCES

I. Dreisbach

Chamberlain

Management

“a

experience.

The letter

SF,

de-

symptom-specific

of intoxication

criticism of 9 of the measures, although the first (establishing proper ventilation)

in their

7.

and associates either did not read my paper drastically misunderstood it. They ignored

case presentation’ on the basis voted to 1 of 15 cases discussed. measures

Reply

Klawans

Alexander

for Emergency

Medical Economics Co. 1974 Burks iS, Walker JE, Rumack BH, et al: Tricyclic antidepressant poisoning: reversal of coma, choreoathetosis, and myoclonus by physostigmine. JAMA 230: 1405-1407, 1974 Duvoisin RC, Katz R: Reversal of central anticholinergic syndrome in man by physostigmine. JAMA 206:1963-1965, 1968 Snyder BD, Blonde L, McWhirter WR: Reversal of amitriptyline intoxication by physostigmine. JAMA 230:1433-1434, 1974 Granacher RP, Baldessarini RJ: Physostigmine. Arch Gen Psychiatry 32:375-380, 1975 Spiker DG, Weiss AN, Chang 55, et al: Tricyclic antidepressant overdose: clinical presentation and plasma levels. Clin Pharmacol 18:539-546, 1975

3.

1975

ROBERT

NS,

Manual

SIR:

for

the

I heartily

tonia: Prediction Richard Abrams,

of Catatonia

Diagnosis concur

with

of Response M.D. and ,

the

thesis

presented

in “Cata-

to Somatic Treatments’ Michael Alan Taylor,



by

M.D.

Overdosing the tricyclic overdose patient.

LETTERS TO THE competency-based model to psychiatric education for medical students. Medical educators have applied many of the principles of compet...
444KB Sizes 0 Downloads 0 Views